COMPANY

Eleison Pharmaceuticals

HQ: Princeton, NJ source · eleison-pharma.com ↗ · Mid-Atlantic

Keywords: oncology cancer Metastatic Pancreatic Adenocarcinoma Pulmonary Relapse of Osteosarcoma Soft Tissue Sarcoma Ovarian Cancer Glufosfamide

Location: Princeton, NJ · source · Oct 15, 2026

Profile checked Oct 10, 2026

Timeline

2014-04 Trial start Phase 3: Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer source ↗
2012-08 Trial start 2: Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma source ↗
2007-03 Trial start Phase 2: Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma source ↗
2007-01 Trial start Phase 2: Safety and Efficacy Study of Glufosfamide in Ovarian Cancer source ↗

2028-03 (ESTIMATED) · Phase 3 · Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer · NCT01954992

Estimated primary completion per ClinicalTrials.gov. Dates move.

Record	Title	Phase	Status	Start	Primary completion
NCT01954992	Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer	Phase 3	Recruiting	2014-04	2028-03 (estimated)
NCT01650090	Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma	2	Completed	2012-08	2018-11 (actual)
NCT00441467	Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma	Phase 2	Completed	2007-03	2008-10 (actual)
NCT00442598	Safety and Efficacy Study of Glufosfamide in Ovarian Cancer	Phase 2	Terminated	2007-01	2008-04 (actual)